Come up with a name for your new list and we'll add to it:
ReFlow Therapeutics raised a round of funding on February 01, 2017. Investors include
Swiss Commission of Technology and Innovation.
ReFlow Therapeutics develops diagnostic and therapeutic medical devices for improving microvascular obstructions after a heart attack.…